...
首页> 外文期刊>Kidney international. >GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy
【24h】

GMP-17-positive T-lymphocytes in renal tubules predict progression in early stages of IgA nephropathy

机译:肾小管中的GMP-17阳性T淋巴细胞可预测IgA肾病早期阶段的进展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Treatment of patients with IgA nephropathy (IgAN) depends on a reliable assessment of disease progression based on measurements of glomerular filtration rate (GFR), proteinuria, hypertension, and tubulointerstitial changes. We sought to determine whether progression could be predicted from analysis of glomerular and tubulointerstitial inflammation in biopsies taken at an early stage of IgAN. We retrospectively analyzed biopsies from 50 patients, relating the subsequent clinical course to infiltration with B- and T-lymphocytes, granule membrane protein of 17kDa (GMP-17) positive cytotoxic T cells, macrophages, fibroblasts, and tubulointerstitial expression of human leukocyte antigen-D related (HLA-DR). At biopsy, 19 patients had decreased GFR while 13 of 31 patients with normal GFR and progressive IgAN differed significantly from 18 non-progressors in the level of proteinuria and in the severity of scores for mesangial proliferation, tubular atrophy, interstitial fibrosis, and interstitial infiltrates. On multivariate regression analysis these differences disappeared; however, associations with GMP-17-positive cytotoxic T-lymphocytes in intact renal tubules and of B-lymphocytes in the interstitium remained significant. Our study may have identified a marker of disease progression in early stages of IgAN.
机译:IgA肾病(IgAN)患者的治疗取决于对肾小球滤过率(GFR),蛋白尿,高血压和肾小管间质变化的测量结果,对疾病进展的可靠评估。我们试图确定是否可以通过对在IgAN早期进行的活检中的肾小球和肾小管间质炎症进行分析来预测进展。我们回顾性分析了50例患者的活组织检查结果,并将其随后的临床过程与B和T淋巴细胞浸润,17kDa的颗粒膜蛋白(GMP-17)阳性细胞毒性T细胞,巨噬细胞,成纤维细胞以及人类白细胞抗原的肾小管间质表达相关。与D相关(HLA-DR)。活检时,GFR降低的19例患者,而GFR正常且IgAN进行性的31例患者中的13例在蛋白尿水平和肾小球膜增生,肾小管萎缩,间质纤维化和间质浸润评分的严重程度方面与18个非进展者显着不同。 。经多元回归分析,这些差异消失了。然而,与完整肾小管中的GMP-17阳性细胞毒性T淋巴细胞和间质组织中的B淋巴细胞的关联仍然很显着。我们的研究可能已经确定了IgAN早期疾病进展的标志。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号